BDNF in schizophrenia, depression and corresponding animal models.

Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10(4):345-52. DOI: 10.1038/sj.mp.4001637. PubMed PMID: 15655562.

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol. 1997;142(2):278-87. DOI: 10.1006/taap.1996.8034. PubMed PMID: 9070350.

Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.

Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt H-U, et al. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci. 2006;26(21):5794-9. DOI: 10.1523/JNEUROSCI.0372-06.2006. PubMed PMID: 16723537.

Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol.

Karniol IG, Carlini EA. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacologia. 1973;33(1):53-70. PubMed PMID: 4358666.

Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.

Bornheim LM, Grillo MP. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol. 1998;11(10):1209-16. DOI: 10.1021/tx9800598. PubMed PMID: 9778318.

Genetic Targeting of the Albumin Locus to Treat Hemophilia.

Davidoff AM, Nathwani AC. Genetic Targeting of the Albumin Locus to Treat Hemophilia. N Engl J Med. 2016;374(13):1288-90. DOI: 10.1056/NEJMcibr1600347. PubMed PMID: 27028920.

Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies.

Jacob JA. Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies. JAMA. 2016;315(15):1550-2. DOI: 10.1001/jama.2016.0082. PubMed PMID: 27027696.

Burning Fat by Bugging the System.

Rosen ED. Burning Fat by Bugging the System. N Engl J Med. 2016;374(9):885-7. DOI: 10.1056/NEJMcibr1515457. PubMed PMID: 26962910.

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.

Dewey FE, Gusarova V, O'Dushlaine C, Gottesman O, Trejos J, Hunt C, et al. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med. 2016;374(12):1123-33. DOI: 10.1056/NEJMoa1510926. PubMed PMID: 26933753.

Antidepressant properties of bioactive fractions from the extract of Crocus sativus L.

Wang Y, Han T, Zhu Y, Zheng C-J, Ming Q-L, Rahman K, et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med. 2010;64(1):24-30. DOI: 10.1007/s11418-009-0360-6. PubMed PMID: 19787421.